Annual report pursuant to Section 13 and 15(d)

SUBSEQUENT EVENTS (Details)

v3.24.0.1
SUBSEQUENT EVENTS (Details) - USD ($)
$ in Thousands
 2 Months Ended 12 Months Ended
Feb. 01, 2024
Mar. 07, 2024
Dec. 31, 2023
Dec. 31, 2022
Subsequent Event [Line Items]        
Common stock issued as purchase consideration     $ 2,994 $ 2,212
Subsequent Event | Medleaf        
Subsequent Event [Line Items]        
Consideration transferred $ 5,250      
Cash paid for acquisition 2,000      
Note payable 2,000      
Common stock issued as purchase consideration 1,250      
Business acquisition, advance payments $ 500      
Common stock        
Subsequent Event [Line Items]        
Shares granted under royalty agreement (in shares)     13,007  
Shares granted under royalty agreement     $ 5  
Common stock | Subsequent Event        
Subsequent Event [Line Items]        
Shares granted under royalty agreement (in shares)   3,614    
Shares granted under royalty agreement   $ 2